Global News

Chan Zuckerberg Initiative to acquire AI startup Meta

Tuesday, January 24, 2017

iGan Partners is thrilled to announce the pending acquisition of its portfolio company, Meta, by the Chan Zuckerberg Initiative. Launched in 2015 by Mark Zuckerberg and Dr. Priscilla Chan, the Chan Zuckerberg Initiative is dedicated to advancing human potential and promoting equal opportunity, with a current focus on scientific research, education, and building strong communities. The goal of their science initiative is to cure, prevent, or manage all diseases by the end of this century.

[Read More]

Acutus Medical named a “Fierce 15” Medical Device Companies of 2016

Monday, January 23, 2017

Acutus Medical has been named by FierceMedicalDevices as one of 2016’s Fierce 15 med tech companies, designating it as one of the most promising private med tech companies in the industry. Acutus Medical is a company committed to transforming the lives of millions of patients by providing electrophysiologists (EPs) a highly unique, dual platform portfolio of breakthrough products that image, diagnose and treat complex arrhythmias.

[Read More]

Bioclinica hires Kraus, Zaim, Levy assume key roles

Monday, January 23, 2017

Bioclinica, a provider of specialized science and technology-enabled services supporting clinical trials, has announced three executive additions to its global Medical Imaging & Biomarkers leadership team. With global headquarters in Princeton, New Jersey, Bioclinica’s Medical Imaging & Biomarkers business segment is the world clinical trial leader in medical imaging, providing cardiac safety monitoring services, specialized biochemical marker analysis, and clinical lab services in the Bioclinica molecular marker laboratory. Joining Bioclinica are Andrew Kraus, chief operating officer; Souhil Zaim, M.D., head of Global Medical and Science Affairs; and Sara Levy, vice president, Client Services. All three will report to David Herron, president, Medical Imaging & Biomarkers.

[Read More]

Caris Life Sciences, Lustgarten Foundation collaborate

Monday, January 23, 2017

Caris Life Sciences, an innovator in molecular science, and the Lustgarten Foundation, a private funder of pancreatic cancer research, are collaborating to support a clinical trial evaluating the impact of immunotherapy in the treatment of pancreatic cancer. Caris is providing clinical trial enrollment services to identify potential trial candidates based on biomarker expression results and facilitate communication between treating physicians and study investigators. The Lustgarten Foundation is a sponsor of the study for pancreatic cancer patients in support of its mission to advance scientific and medical research related to the diagnosis, treatment and cure of pancreatic cancer. [Read More]

BASF, Nuritas partner on peptide ingredients through artificial intelligence

Monday, January 23, 2017

BASF Human Nutrition and Nuritas have announced a collaboration that will see the commercialization and discovery of health-benefiting bioactive peptide networks within specific target areas of significant value. Peptides are biologically occurring short chains of amino acids that act as potent signaling molecules in the body. The peptide networks of focus in this collaboration are natural, food-derived, patented and of significant benefit to the health of consumers. These health benefits include for example anti-inflammatory activities. 

[Read More]

FDA Oncology Center of Excellence launches

Monday, January 23, 2017

The FDA is establishing the Oncology Center of Excellence (OCE) and appointing Dr. Richard Pazdur as its director. This will make oncology the first disease area to have a coordinated clinical review of drugs, biologics and devices across the agency’s three medical product centers.

[Read More]

DaVita, Prism choose Verified Clinical Trials to prevent duplicate enrollment

Friday, January 20, 2017

DaVita Clinical Research (DCR), a specialty CRO with services spanning the full spectrum of drug and device development, and Prism Clinical Research, a provider of fully integrated clinical research services to pharma/device companies and clinicians, have announced Verified Clinical Trials (VCT) has been selected by both companies as an exclusive provider to further prevent duplicate enrollment in clinical trials.

[Read More]